Should Avoid Pfizer? Here's the Key Risk to Watch Today
Pfizer has been a market mover, but recent shifts in demand and patent timelines raise concerns. This guide breaks do...
Some lenders weigh soft pulls differently. Knowing each approach helps you tailor your rate-shopping and application timing.
10,560 articlesPfizer has been a market mover, but recent shifts in demand and patent timelines raise concerns. This guide breaks do...
A January 12, 2026 bill aims to ban lawmakers and families from buying stocks, with public notice and hefty penalties...
Chord Energy reports strong 2025 results driven by Williston Basin efficiency, but investors question whether this wi...
Retail traders drove a large share of leveraged ETF activity in late 2025 as markets swung. This piece examines the p...
Investors are weighing bets on critical metals as supply chains shift and demand from EVs and renewables climbs. This...
As AI drives demand for faster memory, Micron sits at the center of a cyclical industry that can fuel outsized moves....
Evernorth Holdings, a Ripple-backed company holding 473 million XRP, filed an S-4 to go public on Nasdaq through a $1...
Hycroft Mining stock dropped 18% this week as gold and silver prices slid and investors weighed development risk. Thi...
A top OpenAI cofounder reveals he hasn’t written code for months, signaling a shift toward agentic AI and raising que...
Insiders are quietly loading up on fintech stocks even as markets wobble. This article explains what those moves coul...
When the stock market's fear index climbs, headlines shout risk. Yet patient investors leverage fear to reassess plan...
Jim Cramer’s blunt message for 2026 is clear: if you only tech stocks, you’re taking on unnecessary risk. This articl...